BOLONDI, CECILIA

BOLONDI, CECILIA  

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.014 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease Tarozzi A.; Bartolini M.; Piazzi L.; Valgimigli L.; Amorati R.; Bolondi C.; Djemil A.; Mancini F....; Andrisano V.; Rampa A. 2014-01-01 PHARMACOLOGY RESEARCH & PERSPECTIVES - 1.01 Articolo in rivista prp20002-e00023.pdf
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease Morroni F.; Tarozzi A.; Sita G.; Bolondi C.; Zolezzi Moraga JM;
Cantelli-Forti G.; Hrelia P.
2013-01-01 NEUROTOXICOLOGY - 1.01 Articolo in rivista -
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line. TAROZZI A.; F. MORRONI; C. BOLONDI; G. SITA; P. HRELIA; A. DJEMIL; G. CANTELLI FORTI 2012-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-13-10899-v2.pdf
Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. Tarozzi A.; Merlicco A.; Morroni F.; Bolondi C.; Di Iorio P.; Ciccarelli R.; Romano S.; Giuliani ...P.; Hrelia P. 2010-01-01 JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS - 1.01 Articolo in rivista -
Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity. Tarozzi A; Morroni F; Merlicco A; Bolondi C; Teti G; Falconi M; Cantelli-Forti G; Hrelia P. 2010-01-01 NEUROSCIENCE LETTERS - 1.01 Articolo in rivista -
Isothiocyanates as potentials alzheimer's disease-modifying drugs. BOLONDI C.; A. TAROZZI; F. MORRONI; A. MERLICCO; G. CANTELLI FORTI; P. HRELIA 2009-01-01 - Società Italiana di Farmacologia 4.02 Riassunto (Abstract) -